SVB Wealth LLC Has $541,000 Stock Holdings in Sanofi (NASDAQ:SNY)

SVB Wealth LLC trimmed its position in Sanofi (NASDAQ:SNY – Get Rating) by 10.1% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 14,210 shares of the company’s stock after selling 1,599 shares during the period. SVB Wealth LLC’s holdings in Sanofi were worth $541,000 at the end of the most recent quarter.

A number of other hedge funds have also modified their holdings of SNY. Fairfield Bush & CO. bought a new stake in Sanofi during the 1st quarter worth approximately $26,000. Eagle Bay Advisors LLC bought a new stake in Sanofi during the 2nd quarter worth approximately $28,000. Pinnacle Bancorp Inc. increased its stake in Sanofi by 53.2% during the 3rd quarter. Pinnacle Bancorp Inc. now owns 855 shares of the company’s stock worth $33,000 after purchasing an additional 297 shares in the last quarter. Ronald Blue Trust Inc. bought a new stake in Sanofi during the 2nd quarter worth approximately $34,000. Finally, Curi Wealth Management LLC bought a new stake in Sanofi during the 2nd quarter worth approximately $43,000. 10.04% of the stock is currently owned by institutional investors and hedge funds.

Get Sanofi alerts:

Wall Street Analysts Forecast Growth

SNY has been the subject of a number of research reports. Morgan Stanley reissued an “overweight” rating on shares of Sanofi in a research note on Tuesday, December 13th. The Goldman Sachs Group began coverage on shares of Sanofi in a research note on Friday, December 16th. They set a “buy” rating for the company. Finally, TheStreet raised shares of Sanofi from a “c+” rating to a “b-” rating in a research note on Friday, December 2nd. Five analysts have rated the stock with a hold rating, five have issued a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $102.88.

Sanofi Trading Up 0.4 %

NASDAQ SNY opened at $47.60 on Wednesday. The company has a market cap of $120.03 billion, a PE ratio of 16.82, a PEG ratio of 1.44 and a beta of 0.56. The company has a current ratio of 1.42, a quick ratio of 0.55 and a debt-to-equity ratio of 0.20. Sanofi has a 12 month low of $36.91 and a 12 month high of $58.10. The stock has a 50 day moving average of $48.10 and a 200-day moving average of $43.57.

About Sanofi

(Get Rating)

Sanofi engages in the research, production, and distribution of pharmaceutical products. It operates through the following business segments: Pharmaceuticals, Consumer Healthcare, and Vaccines. The Pharmaceuticals segment comprises the commercial operations of the following global franchises: specialty care, diabetes and cardiovascular, established prescription products and generics, and research, development, and production activities.

See Also

• Get a free copy of the StockNews.com research report on Sanofi (SNY)
• LCI Industries Diversification Strategy Pays Off
• Is It Time To Buy The Dip In The Coca-Cola Company 
• Ex-Dividend Date vs. Record Date: What’s the Difference?
• How Does the Consumer Price Index Affect the Stock Market?
• Are Denny’s Corporation Investors Due For A Grand Slam?

Receive News & Ratings for Sanofi Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sanofi and related companies with MarketBeat.com's FREE daily email newsletter.